Listed

Biofrontera Inc.

BFRINasdaqCIK 1858685HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$12.0m, Q2 FY2026
Operating income−$524.0k, Q2 FY2026
Net income−$604.0k, Q2 FY2026
Biofrontera Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m8.9Revenue, Q3 FY2023, three months to 2023-09-30$8.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-14, accession 0001493152-24-045220.Report this figure10.6Revenue, Q4 FY2023, three months to 2023-12-31$10.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-20, accession 0001493152-25-011052. Derived: 12-month figure less the 9-month figure.Report this figure7.9Revenue, Q1 FY2024, three months to 2024-03-31$7.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-15, accession 0001641172-25-011031.Report this figure7.8Revenue, Q2 FY2024, three months to 2024-06-30$7.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-13, accession 0001641172-25-023486.Report this figure9.0Revenue, Q3 FY2024, three months to 2024-09-30$9.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001493152-25-021945.Report this figure12.6Revenue, Q4 FY2024, three months to 2024-12-31$12.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-19, accession 0001493152-26-011625. Derived: 12-month figure less the 9-month figure.Report this figure8.6Revenue, Q1 FY2025, three months to 2025-03-31$8.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001493152-26-023119.Report this figure9.0Revenue, Q2 FY2025, three months to 2025-06-30$9.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001493152-26-037834.Report this figure7.0Revenue, Q3 FY2025, three months to 2025-09-30$7.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-12, accession 0001493152-25-021945.Report this figure17.1Revenue, Q4 FY2025, three months to 2025-12-31$17.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-19, accession 0001493152-26-011625. Derived: 12-month figure less the 9-month figure.Report this figure10.1Revenue, Q1 FY2026, three months to 2026-03-31$10.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-14, accession 0001493152-26-023119.Report this figure12.0Revenue, Q2 FY2026, three months to 2026-06-30$12.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-13, accession 0001493152-26-037834.Report this figure
Cost of revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m0.0Research and development, Q3 FY2023, three months to 2023-09-30$33.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-14, accession 0001493152-24-045220.Report this figure0.0Research and development, Q4 FY2023, three months to 2023-12-31$33.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-20, accession 0001493152-25-011052. Derived: 12-month figure less the 9-month figure.Report this figure0.0Research and development, Q1 FY2024, three months to 2024-03-31$17.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-15, accession 0001641172-25-011031.Report this figure0.6Research and development, Q2 FY2024, three months to 2024-06-30$621.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-13, accession 0001641172-25-023486.Report this figure0.7Research and development, Q3 FY2024, three months to 2024-09-30$669.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001493152-25-021945.Report this figure0.8Research and development, Q4 FY2024, three months to 2024-12-31$783.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-19, accession 0001493152-26-011625. Derived: 12-month figure less the 9-month figure.Report this figure1.2Research and development, Q1 FY2025, three months to 2025-03-31$1.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001493152-26-023119.Report this figure0.9Research and development, Q2 FY2025, three months to 2025-06-30$870.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001493152-26-037834.Report this figure0.9Research and development, Q3 FY2025, three months to 2025-09-30$854.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001493152-25-021945.Report this figure0.8Research and development, Q4 FY2025, three months to 2025-12-31$787.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-19, accession 0001493152-26-011625. Derived: 12-month figure less the 9-month figure.Report this figure0.9Research and development, Q1 FY2026, three months to 2026-03-31$900.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001493152-26-023119.Report this figure0.4Research and development, Q2 FY2026, three months to 2026-06-30$448.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001493152-26-037834.Report this figure
Selling, general and administrative$m8.6Selling, general and administrative, Q3 FY2023, three months to 2023-09-30$8.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2023-11-09, accession 0001493152-23-040132.Report this figure9.1Selling, general and administrative, Q4 FY2023, three months to 2023-12-31$9.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2024-03-15, accession 0001493152-24-010133. Derived: 12-month figure less the 9-month figure.Report this figure9.3Selling, general and administrative, Q1 FY2024, three months to 2024-03-31$9.3m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-05-15, accession 0001641172-25-011031.Report this figure7.9Selling, general and administrative, Q2 FY2024, three months to 2024-06-30$7.9m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-08-13, accession 0001641172-25-023486.Report this figure8.4Selling, general and administrative, Q3 FY2024, three months to 2024-09-30$8.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-12, accession 0001493152-25-021945.Report this figure8.2Selling, general and administrative, Q4 FY2024, three months to 2024-12-31$8.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-19, accession 0001493152-26-011625. Derived: 12-month figure less the 9-month figure.Report this figure8.7Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$8.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-14, accession 0001493152-26-023119.Report this figure10.5Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$10.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-13, accession 0001493152-26-037834.Report this figure10.0Selling, general and administrative, Q3 FY2025, three months to 2025-09-30$10.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2025-11-12, accession 0001493152-25-021945.Report this figure8.5Selling, general and administrative, Q4 FY2025, three months to 2025-12-31$8.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-K filed 2026-03-19, accession 0001493152-26-011625. Derived: 12-month figure less the 9-month figure.Report this figure11.0Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$11.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-14, accession 0001493152-26-023119.Report this figure9.6Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$9.6m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-13, accession 0001493152-26-037834.Report this figure
Operating income$m(4.6)Operating income, Q3 FY2023, three months to 2023-09-30−$4.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-14, accession 0001493152-24-045220.Report this figure(3.9)Operating income, Q4 FY2023, three months to 2023-12-31−$3.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-20, accession 0001493152-25-011052. Derived: 12-month figure less the 9-month figure.Report this figure(5.5)Operating income, Q1 FY2024, three months to 2024-03-31−$5.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-15, accession 0001641172-25-011031.Report this figure(5.1)Operating income, Q2 FY2024, three months to 2024-06-30−$5.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-13, accession 0001641172-25-023486.Report this figure(5.0)Operating income, Q3 FY2024, three months to 2024-09-30−$5.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001493152-25-021945.Report this figure(1.7)Operating income, Q4 FY2024, three months to 2024-12-31−$1.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-19, accession 0001493152-26-011625. Derived: 12-month figure less the 9-month figure.Report this figure(4.5)Operating income, Q1 FY2025, three months to 2025-03-31−$4.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001493152-26-023119.Report this figure(5.1)Operating income, Q2 FY2025, three months to 2025-06-30−$5.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001493152-26-037834.Report this figure(6.3)Operating income, Q3 FY2025, three months to 2025-09-30−$6.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001493152-25-021945.Report this figure4.6Operating income, Q4 FY2025, three months to 2025-12-31$4.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-19, accession 0001493152-26-011625. Derived: 12-month figure less the 9-month figure.Report this figure(4.3)Operating income, Q1 FY2026, three months to 2026-03-31−$4.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001493152-26-023119.Report this figure(0.5)Operating income, Q2 FY2026, three months to 2026-06-30−$524.0k. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001493152-26-037834.Report this figure
Interest expense$m0.1Interest expense, Q3 FY2023, three months to 2023-09-30$142.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-09, accession 0001493152-23-040132.Report this figure(0.0)Interest expense, Q4 FY2023, three months to 2023-12-31−$36.0k. XBRL concept us-gaap:InterestExpense. 10-K filed 2024-03-15, accession 0001493152-24-010133. Derived: 12-month figure less the 9-month figure.Report this figure1.4Interest expense, Q1 FY2024, three months to 2024-03-31$1.4m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-15, accession 0001493152-24-019878.Report this figure0.6Interest expense, Q2 FY2024, three months to 2024-06-30$620.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-08-14, accession 0001493152-24-032216.Report this figurenot reportednot reported0.1Interest expense, Q1 FY2025, three months to 2025-03-31$120.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2025-05-15, accession 0001641172-25-011031.Report this figurenot reportednot reportednot reportednot reportednot reported
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$1.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-14, accession 0001493152-24-045220.Report this figure(0.0)Income tax, Q4 FY2023, three months to 2023-12-31−$6.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-20, accession 0001493152-25-011052. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$1.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-15, accession 0001641172-25-011031.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$20.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-13, accession 0001641172-25-023486.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$3.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001493152-25-021945.Report this figure(0.0)Income tax, Q4 FY2024, three months to 2024-12-31−$3.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-19, accession 0001493152-26-011625. Derived: 12-month figure less the 9-month figure.Report this figure(0.0)Income tax, Q1 FY2025, three months to 2025-03-31−$1.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-14, accession 0001493152-26-023119.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$21.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-13, accession 0001493152-26-037834.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$6.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001493152-25-021945.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-19, accession 0001493152-26-011625. Derived: 12-month figure less the 9-month figure.Report this figurenot reported0.0Income tax, Q2 FY2026, three months to 2026-06-30$23.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-13, accession 0001493152-26-037834.Report this figure
Net income$m(6.3)Net income, Q3 FY2023, three months to 2023-09-30−$6.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-14, accession 0001493152-24-045220.Report this figure3.5Net income, Q4 FY2023, three months to 2023-12-31$3.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-20, accession 0001493152-25-011052. Derived: 12-month figure less the 9-month figure.Report this figure(10.4)Net income, Q1 FY2024, three months to 2024-03-31−$10.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-15, accession 0001641172-25-011031.Report this figure(0.3)Net income, Q2 FY2024, three months to 2024-06-30−$257.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-13, accession 0001641172-25-023486.Report this figure(5.7)Net income, Q3 FY2024, three months to 2024-09-30−$5.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001493152-25-021945.Report this figure(1.4)Net income, Q4 FY2024, three months to 2024-12-31−$1.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-19, accession 0001493152-26-011625. Derived: 12-month figure less the 9-month figure.Report this figure(4.2)Net income, Q1 FY2025, three months to 2025-03-31−$4.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001493152-26-023119.Report this figure(5.3)Net income, Q2 FY2025, three months to 2025-06-30−$5.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001493152-26-037834.Report this figure(6.6)Net income, Q3 FY2025, three months to 2025-09-30−$6.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001493152-25-021945.Report this figure5.6Net income, Q4 FY2025, three months to 2025-12-31$5.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-19, accession 0001493152-26-011625. Derived: 12-month figure less the 9-month figure.Report this figure(4.8)Net income, Q1 FY2026, three months to 2026-03-31−$4.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001493152-26-023119.Report this figure(0.6)Net income, Q2 FY2026, three months to 2026-06-30−$604.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001493152-26-037834.Report this figure
Diluted EPS$ per share(4.64)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$4.64 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0001493152-24-045220.Report this figurenot reported(2.88)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$2.88 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-15, accession 0001641172-25-011031.Report this figure(0.05)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-13, accession 0001641172-25-023486.Report this figure(0.98)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.98 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001493152-25-021945.Report this figurenot reported(0.47)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.47 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001493152-26-023119.Report this figure(0.57)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.57 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001493152-26-037834.Report this figure(0.62)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.62 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-12, accession 0001493152-25-021945.Report this figurenot reported(0.41)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.41 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001493152-26-023119.Report this figure(0.05)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001493152-26-037834.Report this figure
Basic EPS$ per share(4.64)Basic EPS, Q3 FY2023, three months to 2023-09-30−$4.64 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0001493152-24-045220.Report this figurenot reported(2.88)Basic EPS, Q1 FY2024, three months to 2024-03-31−$2.88 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-15, accession 0001641172-25-011031.Report this figure(0.05)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-13, accession 0001641172-25-023486.Report this figure(0.98)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.98 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001493152-25-021945.Report this figurenot reported(0.47)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.47 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001493152-26-023119.Report this figure(0.57)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.57 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001493152-26-037834.Report this figure(0.62)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.62 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001493152-25-021945.Report this figurenot reported(0.41)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.41 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001493152-26-023119.Report this figure(0.05)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001493152-26-037834.Report this figure

Balance sheet

Cash and equivalents$4.7m, Q2 FY2026
Shareholders' equity$6.0m, Q2 FY2026
Biofrontera Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m3.4Cash and equivalents, Q3 FY2023, at 2023-09-30$3.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-09, accession 0001493152-23-040132.Report this figure1.3Cash and equivalents, FY2023, at 2023-12-31$1.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-20, accession 0001493152-25-011052.Report this figure3.8Cash and equivalents, Q1 FY2024, at 2024-03-31$3.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-15, accession 0001493152-24-019878.Report this figure4.4Cash and equivalents, Q2 FY2024, at 2024-06-30$4.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-14, accession 0001493152-24-032216.Report this figure2.9Cash and equivalents, Q3 FY2024, at 2024-09-30$2.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-14, accession 0001493152-24-045220.Report this figure5.9Cash and equivalents, FY2024, at 2024-12-31$5.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-19, accession 0001493152-26-011625.Report this figure1.8Cash and equivalents, Q1 FY2025, at 2025-03-31$1.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-15, accession 0001641172-25-011031.Report this figure7.2Cash and equivalents, Q2 FY2025, at 2025-06-30$7.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-13, accession 0001641172-25-023486.Report this figure3.4Cash and equivalents, Q3 FY2025, at 2025-09-30$3.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001493152-25-021945.Report this figure6.4Cash and equivalents, FY2025, at 2025-12-31$6.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001493152-26-037834.Report this figure6.3Cash and equivalents, Q1 FY2026, at 2026-03-31$6.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001493152-26-023119.Report this figure4.7Cash and equivalents, Q2 FY2026, at 2026-06-30$4.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001493152-26-037834.Report this figure
Current assets$m29.6Current assets, Q3 FY2023, at 2023-09-30$29.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0001493152-23-040132.Report this figure23.1Current assets, FY2023, at 2023-12-31$23.1m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-20, accession 0001493152-25-011052.Report this figure20.2Current assets, Q1 FY2024, at 2024-03-31$20.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-15, accession 0001493152-24-019878.Report this figure17.5Current assets, Q2 FY2024, at 2024-06-30$17.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-14, accession 0001493152-24-032216.Report this figure16.9Current assets, Q3 FY2024, at 2024-09-30$16.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0001493152-24-045220.Report this figure20.7Current assets, FY2024, at 2024-12-31$20.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-19, accession 0001493152-26-011625.Report this figure15.3Current assets, Q1 FY2025, at 2025-03-31$15.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-15, accession 0001641172-25-011031.Report this figure18.8Current assets, Q2 FY2025, at 2025-06-30$18.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-13, accession 0001641172-25-023486.Report this figure14.4Current assets, Q3 FY2025, at 2025-09-30$14.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001493152-25-021945.Report this figure18.1Current assets, FY2025, at 2025-12-31$18.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001493152-26-037834.Report this figure13.2Current assets, Q1 FY2026, at 2026-03-31$13.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-14, accession 0001493152-26-023119.Report this figure12.4Current assets, Q2 FY2026, at 2026-06-30$12.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001493152-26-037834.Report this figure
Total assets$m34.1Total assets, Q3 FY2023, at 2023-09-30$34.1m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0001493152-23-040132.Report this figure27.9Total assets, FY2023, at 2023-12-31$27.9m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-20, accession 0001493152-25-011052.Report this figure24.6Total assets, Q1 FY2024, at 2024-03-31$24.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-15, accession 0001493152-24-019878.Report this figure21.6Total assets, Q2 FY2024, at 2024-06-30$21.6m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-14, accession 0001493152-24-032216.Report this figure18.5Total assets, Q3 FY2024, at 2024-09-30$18.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0001493152-24-045220.Report this figure22.1Total assets, FY2024, at 2024-12-31$22.1m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-19, accession 0001493152-26-011625.Report this figure16.6Total assets, Q1 FY2025, at 2025-03-31$16.6m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-15, accession 0001641172-25-011031.Report this figure20.1Total assets, Q2 FY2025, at 2025-06-30$20.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-13, accession 0001641172-25-023486.Report this figure15.4Total assets, Q3 FY2025, at 2025-09-30$15.4m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001493152-25-021945.Report this figure28.6Total assets, FY2025, at 2025-12-31$28.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001493152-26-037834.Report this figure24.8Total assets, Q1 FY2026, at 2026-03-31$24.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-14, accession 0001493152-26-023119.Report this figure24.1Total assets, Q2 FY2026, at 2026-06-30$24.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001493152-26-037834.Report this figure
Current liabilities$m29.1Current liabilities, Q3 FY2023, at 2023-09-30$29.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0001493152-23-040132.Report this figure18.1Current liabilities, FY2023, at 2023-12-31$18.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-20, accession 0001493152-25-011052.Report this figure14.0Current liabilities, Q1 FY2024, at 2024-03-31$14.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-15, accession 0001493152-24-019878.Report this figure9.3Current liabilities, Q2 FY2024, at 2024-06-30$9.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-14, accession 0001493152-24-032216.Report this figure11.0Current liabilities, Q3 FY2024, at 2024-09-30$11.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0001493152-24-045220.Report this figure12.0Current liabilities, FY2024, at 2024-12-31$12.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-19, accession 0001493152-26-011625.Report this figure11.0Current liabilities, Q1 FY2025, at 2025-03-31$11.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-15, accession 0001641172-25-011031.Report this figure19.7Current liabilities, Q2 FY2025, at 2025-06-30$19.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-13, accession 0001641172-25-023486.Report this figure12.6Current liabilities, Q3 FY2025, at 2025-09-30$12.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001493152-25-021945.Report this figure11.9Current liabilities, FY2025, at 2025-12-31$11.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001493152-26-037834.Report this figure10.9Current liabilities, Q1 FY2026, at 2026-03-31$10.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-14, accession 0001493152-26-023119.Report this figure10.5Current liabilities, Q2 FY2026, at 2026-06-30$10.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001493152-26-037834.Report this figure
Total liabilities$m33.1Total liabilities, Q3 FY2023, at 2023-09-30$33.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0001493152-23-040132.Report this figure23.1Total liabilities, FY2023, at 2023-12-31$23.1m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-20, accession 0001493152-25-011052.Report this figure26.4Total liabilities, Q1 FY2024, at 2024-03-31$26.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-15, accession 0001493152-24-019878.Report this figure10.7Total liabilities, Q2 FY2024, at 2024-06-30$10.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-14, accession 0001493152-24-032216.Report this figure13.0Total liabilities, Q3 FY2024, at 2024-09-30$13.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0001493152-24-045220.Report this figure17.7Total liabilities, FY2024, at 2024-12-31$17.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-19, accession 0001493152-26-011625.Report this figure16.1Total liabilities, Q1 FY2025, at 2025-03-31$16.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-15, accession 0001641172-25-011031.Report this figure24.8Total liabilities, Q2 FY2025, at 2025-06-30$24.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-13, accession 0001641172-25-023486.Report this figure18.0Total liabilities, Q3 FY2025, at 2025-09-30$18.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-12, accession 0001493152-25-021945.Report this figure18.1Total liabilities, FY2025, at 2025-12-31$18.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001493152-26-037834.Report this figure18.7Total liabilities, Q1 FY2026, at 2026-03-31$18.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-14, accession 0001493152-26-023119.Report this figure18.1Total liabilities, Q2 FY2026, at 2026-06-30$18.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001493152-26-037834.Report this figure
Short-term borrowings$mnot reported3.9Short-term borrowings, FY2023, at 2023-12-31$3.9m. XBRL concept us-gaap:ShortTermBorrowings. 10-K filed 2025-03-20, accession 0001493152-25-011052.Report this figure2.4Short-term borrowings, Q1 FY2024, at 2024-03-31$2.4m. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2024-05-15, accession 0001493152-24-019878.Report this figure0.3Short-term borrowings, Q2 FY2024, at 2024-06-30$296.0k. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2024-08-14, accession 0001493152-24-032216.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m1.0Shareholders' equity, Q3 FY2023, at 2023-09-30$1.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-14, accession 0001493152-24-045220.Report this figure4.8Shareholders' equity, FY2023, at 2023-12-31$4.8m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-19, accession 0001493152-26-011625.Report this figure(5.4)Shareholders' equity, Q1 FY2024, at 2024-03-31−$5.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-13, accession 0001641172-25-023486.Report this figure10.9Shareholders' equity, Q2 FY2024, at 2024-06-30$10.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001493152-25-021945.Report this figure5.5Shareholders' equity, Q3 FY2024, at 2024-09-30$5.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001493152-25-021945.Report this figure4.4Shareholders' equity, FY2024, at 2024-12-31$4.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037834.Report this figure0.5Shareholders' equity, Q1 FY2025, at 2025-03-31$469.0k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037834.Report this figure(4.7)Shareholders' equity, Q2 FY2025, at 2025-06-30−$4.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037834.Report this figure(2.6)Shareholders' equity, Q3 FY2025, at 2025-09-30−$2.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001493152-25-021945.Report this figure10.5Shareholders' equity, FY2025, at 2025-12-31$10.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037834.Report this figure6.1Shareholders' equity, Q1 FY2026, at 2026-03-31$6.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037834.Report this figure6.0Shareholders' equity, Q2 FY2026, at 2026-06-30$6.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001493152-26-037834.Report this figure

Cash flow

Operating cash flow−$1.7m, Q2 FY2026
Capital expenditure$0, Q2 FY2026
Biofrontera Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k(2,004)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$2.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0001493152-24-045220. Derived: 9-month figure less the 6-month figure.Report this figure(8,866)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$8.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-20, accession 0001493152-25-011052. Derived: 12-month figure less the 9-month figure.Report this figure(3,325)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$3.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-15, accession 0001641172-25-011031.Report this figure(4,720)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$4.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-13, accession 0001641172-25-023486. Derived: 6-month figure less the 3-month figure.Report this figure(1,208)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$1.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001493152-25-021945. Derived: 9-month figure less the 6-month figure.Report this figure(1,017)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$1.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-19, accession 0001493152-26-011625. Derived: 12-month figure less the 9-month figure.Report this figure(4,117)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$4.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001493152-26-023119.Report this figure(3,045)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$3.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001493152-26-037834. Derived: 6-month figure less the 3-month figure.Report this figure(3,823)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$3.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001493152-25-021945. Derived: 9-month figure less the 6-month figure.Report this figure(2,376)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$2.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-19, accession 0001493152-26-011625. Derived: 12-month figure less the 9-month figure.Report this figure(70.0)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$70.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001493152-26-023119.Report this figure(1,658)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$1.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001493152-26-037834. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$k0.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-14, accession 0001493152-24-045220. Derived: 9-month figure less the 6-month figure.Report this figure(9.0)Capital expenditure, Q4 FY2023, three months to 2023-12-31−$9.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-20, accession 0001493152-25-011052. Derived: 12-month figure less the 9-month figure.Report this figure57.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$57.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-15, accession 0001641172-25-011031.Report this figure(48.0)Capital expenditure, Q2 FY2024, three months to 2024-06-30−$48.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-13, accession 0001641172-25-023486. Derived: 6-month figure less the 3-month figure.Report this figure0.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001493152-25-021945. Derived: 9-month figure less the 6-month figure.Report this figure1.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$1.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-19, accession 0001493152-26-011625. Derived: 12-month figure less the 9-month figure.Report this figure3.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$3.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001493152-26-023119.Report this figure1.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$1.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001493152-26-037834. Derived: 6-month figure less the 3-month figure.Report this figure(1.0)Capital expenditure, Q3 FY2025, three months to 2025-09-30−$1.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001493152-25-021945. Derived: 9-month figure less the 6-month figure.Report this figure(1.0)Capital expenditure, Q4 FY2025, three months to 2025-12-31−$1.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-19, accession 0001493152-26-011625. Derived: 12-month figure less the 9-month figure.Report this figure5.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$5.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001493152-26-023119.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001493152-26-037834. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)12.92m, Q2 FY2026
Biofrontera Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares1.1Diluted shares (weighted), Q3 FY2022, three months to 2022-09-301,136,291 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0001493152-23-040132.Report this figure1.3Diluted shares (weighted), Q1 FY2023, three months to 2023-03-311,334,950 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-15, accession 0001493152-24-019878.Report this figure1.4Diluted shares (weighted), Q2 FY2023, three months to 2023-06-301,360,739 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-14, accession 0001493152-24-032216.Report this figure1.4Diluted shares (weighted), Q3 FY2023, three months to 2023-09-301,366,842 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-14, accession 0001493152-24-045220.Report this figure3.6Diluted shares (weighted), Q1 FY2024, three months to 2024-03-313,623,593 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-15, accession 0001641172-25-011031.Report this figure5.1Diluted shares (weighted), Q2 FY2024, three months to 2024-06-305,091,353 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-13, accession 0001641172-25-023486.Report this figure5.8Diluted shares (weighted), Q3 FY2024, three months to 2024-09-305,773,993 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001493152-25-021945.Report this figure8.9Diluted shares (weighted), Q1 FY2025, three months to 2025-03-318,873,932 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001493152-26-023119.Report this figure9.4Diluted shares (weighted), Q2 FY2025, three months to 2025-06-309,351,557 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001493152-26-037834.Report this figure10.8Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3010,776,739 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-12, accession 0001493152-25-021945.Report this figure11.7Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3111,683,323 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001493152-26-023119.Report this figure12.9Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3012,923,710 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001493152-26-037834.Report this figure

Shares outstanding: 14.85mShares outstanding, period not labelled, at 2026-08-1114,852,359 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-13, accession 0001493152-26-037834.Report this figure at Aug 11, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. Listed shows no prices and gives no investment advice.